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expression of renal sodium- and water-transporting proteins. Am J
Physiol Renal Physiol 294: F1373–F1380, 2008. First published
March 5, 2008; doi:10.1152/ajprenal.00613.2007.—Bartter’s syn-
drome represents a group of hereditary salt- and water-losing renal
tubulopathies caused by loss-of-function mutations in proteins medi-
ating or regulating salt transport in the thick ascending limb (TAL) of
Henle’s loop. Mutations in the ROMK channel cause type II antenatal
Bartter’s syndrome that presents with maternal polyhydramnios and
postnatal life-threatening volume depletion. We have developed a
colony of Romk null mice showing a Bartter-like phenotype and with
increased survival to adulthood, suggesting the activation of compen-
satory mechanisms. To test the hypothesis that upregulation of Na-
transporting proteins in segments distal to the TAL contributes to
compensation, we studied expression of salt-transporting proteins in
ROMK-deﬁcient (Romk/) mice. Plasma aldosterone was 40%
higher and urinary PGE2 excretion was 1.5-fold higher in Romk/
compared with wild-type littermates. Semiquantitative immunoblotting
of kidney homogenates revealed decreased abundances of proximal
tubule Na/H exchanger (NHE3) and Na-Pi cotransporter (NaPi-IIa)
and TAL-speciﬁc Na-K-2Cl-cotransporter (NKCC2/BSC1) in
Romk/ mice, while the distal convoluted tubule (DCT)-speciﬁc Na-
Cl cotransporter (NCC/TSC) was markedly increased. The abundance
of the -,-, and -subunits of the epithelial Na channel (ENaC) was
slightly increased, although only differences for -ENaC reached statis-
tical signiﬁcance. Morphometry revealed a fourfold increase in the
fractional volume of DCT but not of connecting tubule (CNT) and
collecting duct (CCD). Consistently, CNT and CD of Romk/ mice
revealed no apparent increase in the luminal abundance of the ENaC
compared with those of wild-type mice. These data suggest that the loss
of ROMK-dependent Na absorption in the TAL is compensated pre-
dominately by upregulation of Na transport in downstream DCT cells.
These adaptive changes in Romk/ mice may help to limit renal Na
loss, and thereby, contribute to survival of these mice.
thick ascending limb of Henle’s loop; distal convoluted tubule;
thiazide-sensitive NaCl cotransporter; renal outer medulla K chan-
nel; hyperprostaglandin E syndrome
HYPERPROSTAGLANDIN E SYNDROME (HPS) represents a geneti-
cally heterogeneous group of hypokalemic renal salt-wasting
tubulopathies characterized by metabolic alkalosis, normoten-
sive hyperaldosteronism, and increased renin and PGE2 pro-
duction (3, 29–31, 34). All HPS subtypes are linked to dys-
function of salt transport in the thick ascending limb (TAL)
(12). Salt absorption by the Na-K-2Cl cotransporter
(NKCC2) in the TAL depends on the luminal availability of
potassium which is recycled across the apical membrane by
K channels formed or dependent on ROMK expression (10,
11). Thus loss-of-function mutations in the ROMK (Kcnj1)
result in HPS (type II Bartter’s syndrome). In a companion
paper, we characterized the renal phenotype of the ROMK null
(Romk/) mouse model of type II Bartter’s syndrome based
on the effects of speciﬁc loop of Henle and distal tubule
diuretics on renal water and electrolyte excretion (4).
Impaired Na transport in the TAL leads to enhanced down-
stream Na delivery to the DCT, connecting tubule (CNT), and
cortical collecting duct (CCD) (for a review, see Refs. 16, 18,
and 25). Previous studies in rats have shown that chronic
inhibition of sodium absorption in the TAL by loop diuretics
like furosemide causes hypertrophy and hyperplasia of the
DCT, CNT, and CCD associated with an increased abundance
of the apical Na-Cl cotransporter (NCC), epithelial Na
channel (ENaC), and basolateral Na-K-ATPase (1, 9, 14,
17, 24, 28). These adaptive mechanisms have been suggested
to play a role in the development of furosemide resistance that
occurs frequently during treatment with loop diuretics (25).
Similar functional adaptations of the distal nephron could help
compensate for derangements of function of the loop of Henle
in HPS. Thus, in the present study, we examined the adaptive
responses in ion transport proteins along the nephron in the
ROMK null mouse model of type II Bartter’s syndrome.
MATERIALS AND METHODS
Mice. The generation of Romk/ and Romk/ mice has been
previously described (21; see also Ref. 4). Survival of Romk/ mice
to adults was 50%. Wild-type Romk/ are genetically identical to
Romk/ mice except for deletion of Kcnj1. All mice were given tap
water ad libitum and maintained on standard rodent chow (1.2% K).
All animal experiments were approved by the Yale Animal Care
Committee.
Urine collection. Mice were housed in metabolic cages with free
access to normal food and water. Urine samples were collected over
16 h into tubes immersed in ice during collection.
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Serum PGE2 and aldosterone measurements. PGE2 concentrations
were determined by using a PGE2 EIA Kit (Cayman Chemical, Ann
Arbor, MI) according to the manufacturer’s instructions. Brieﬂy, after
dilution of urine samples to the optional concentration, 50 l of each
sample was mixed along with a serial dilution of PGE2 standard
samples with appropriate amounts of acetylcholinesterase-labeled
tracer and PGE2 antiserum and incubated at 4°C for 18 h. After the
wells were emptied and rinsed with wash buffer, 200 l of Ellman’s
reagent containing the acetylcholinesterase substrate was added. The
enzyme reaction was carried out on a slow shaker at room temperature
for 1–2 h. The plates were read on a Microplate Reader (Benchmark
Microplate Reader, Bio-Rad) at 405 nm. The results were analyzed
with Cayman Chemical’s computer spreadsheet.
Plasma aldosterone concentrations were measured in blood sam-
ples collected from the carotid artery using an Immuchem Double
Antibody, Aldosterone 125I RIA kit at Yale University’s General
Clinical Research Center. The RIA kit was purchased from ICN
Pharmaceuticals (Costa Mesa, CA).
Antibodies. The antibodies used for immunohistochemistry and
Western blotting are shown in Table 1.
The new sets of antibodies against NKCC2, -ENaC, -ENaC, and
aquaporin-2 (AQP2), were obtained by immunizing rabbits (Pineda
Ab-Production, Berlin, Germany) with keyhole limpet hemocyanin-
coupled synthetic peptides corresponding to amino acid sequences within
mouse NKCC2 (NH2-CEYYRNTGSVSGPKVNRPSLQE-COOH),
-ENaC (NH2-CNYDSLRLQPLDTMESDSEVEAI-COOH), -ENaC
(NH2-CNTLRLDSAFSSQLTDTQLTNEF-COOH), or AQP2 (NH2-
CVELHSPQSLPRGSKA-COOH), similar to previously used sequences
of rat or human isoforms of these proteins (7, 8, 22).
All sera were characterized by immunoﬂuorescence and standard
Western blotting with mouse kidney samples. Speciﬁc binding of the
antibodies to kidney sections (immunoﬂuorescence) and to polyvi-
nylidene diﬂuoride (PVDF) membranes (Western blotting) could be
completely inhibited by preincubation of the antisera with the speciﬁc
peptides used for immunization (see supplementary ﬁgures; all sup-
plementary material is available in the online version of this article at
the journal web site).
Western blotting. The mice were killed, and the kidneys were
rapidly harvested. Total kidneys were homogenized in an ice-cold
K-HEPES buffer (200 mM mannitol, 80 mM K-HEPES, 41 mM
KOH, pH 7.5) with pepstatin, leupeptin, K-EDTA, and phenylmeth-
ylsulfonyl ﬂuoride (PMSF) added as protease inhibitors. The samples
were centrifuged at 1,000 g for 10 min at 4°C, and the supernatant was
saved. Subsequently, the supernatant was centrifuged at 100,000 g for
1 h at 4°C, and the resultant pellet was resuspended in K-HEPES
buffer containing protease inhibitors. After measurement of the total
protein concentration (Bio-Rad Protein kit), 50 g of crude membrane
protein were solubilized in Laemmli sample buffer, and SDS-PAGE
was performed on 10% polyacrylamide gels. For immunoblotting,
proteins were transferred electrophoretically from unstained gels to
PVDF membranes (Immobilon-P, Millipore, Bedford, MA). After
blocking with 5% milk powder in Tris-buffered saline/0.1% Tween 20
for 60 min, the blots were incubated with the primary antibody either
for 2 h at room temperature or overnight at 4°C. After washing and
subsequent blocking, blots were incubated with the secondary anti-
bodies (donkey anti-rabbit 1:10,000 and sheep anti-mouse 1:5,000,
IgG conjugated with horseradish peroxidase, Amersham Life Sci-
ences) for 1 h at room temperature. Antibody binding was detected
with an enhanced chemiluminescence ECL kit (Amersham Pharmacia
Biotech) before exposure to X-ray ﬁlm (Kodak). The protein/actin
ratio was determined and used to calculate the ratio between the
wild-type and ROMK-deﬁcient group using Gauss’ law of error
propagation. All results were tested for signiﬁcance using the unpaired
Student’s t-test, and only results with P 	 0.05 were considered as
statistically signiﬁcant.
Western blot analysis of renin expression. Mouse kidneys were
homogenized in 1–2 ml of extraction buffer (5 mM Tris hydrochlo-
ride, pH 7.5, 2 mM EDTA, 1% SDS, 100 M PMSF, 2 g/ml
leupeptin, and 2 g/ml aprotinin), and centrifuged at 4,000 g for 30
min at 4°C. Protein concentration was determined using a BCA
Protein assay kit (Pierce, Rockford, IL). Forty micrograms of protein
was solubilized in 2
 sample buffer, separated by 10% SDS-PAGE,
and transferred to PVDF membranes using the Mini-Trans blotting
system (Bio-Rad Laboratories, Hercules, CA). Prestained high-range
SDS-PAGE standards were used (Bio-Rad Laboratories). The mem-
branes were blocked for 1 h in 5% nonfat milk/TBS-Tween at room
temperature before incubation with the primary mouse monoclonal
anti-renin antibody (Research Diagnostics) diluted 1:1,000 in 5%
nonfat milk/TBS-Tween overnight at 4°C. After washing, membranes
were incubated with peroxidase-linked anti-mouse IgG antibodies
(Amersham Life Science, Arlington Heights, IL) for 1 h at room
temperature. After washing in TBS-Tween, antigen-antibody com-
plexes were detected using the ECL chemiluminescence kit (ECL,
Amersham Life Science).
Immunohistochemistry. Mice were anesthetized with ketamine/
xylazine (ip). and perfused through the left ventricle with PBS
followed by paraformaldehyde-lysine-periodate ﬁxative (23). Immu-
nohistochemistry was performed as previously described (20). Brieﬂy,
cryosections 5 m thick were incubated overnight at 4°C with
antibodies given in Table 1. Binding sites were revealed by Cy3-
conjugated goat anti-rabbit IgG antibodies. Sections were studied by
epiﬂuorescence on a Zeiss microscope. Histological and morpho-
Table 1. Antibodies used for immunohistochemistry and Western blotting
Antibody Host
Dilution
Source ReferenceWB IF
NHE3 Rabbit 1:5,000 O. Moe 2
NaPi-IIa Rabbit 1:5,000 H. Murer 5
NKCC2 Rabbit 1:5,000 S. Hebert 15
1:20,000 1:20,000 J. Lofﬁng This study
ROMK Rabbit 1:500 1:500 Alamone
NCC Rabbit 1:2,000 1:2,000 J. Lofﬁng 20
AQP2 Rabbit 1:20,000 1:20,000 J. Lofﬁng This study
ENaC Rabbit 1:2,000 1:500 B. Rossier 27
ENaC Rabbit 1:500 B. Rossier 27
1:20,000 1:20,000 J. Lofﬁng This study
ENaC Rabbit 1:400 B. Rossier 27
1:20,000 1:20,000 J. Lofﬁng This study
-Actin Mouse 1:5,000 Sigma
WB, Western blotting; IF, immunoﬂuorescence; isoform 3 Na/H exchanger; type IIa Na-Pi cotransporter; NKCC2, Na-K-2Cl cotransporter; NCC,
Na- Cl cotransporter; AQP2, aquaporin-2; ENaC, epithelial Na channel.
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metrical analysis was performed by two experienced investigators
blinded for the genotype of the animals. Digital images were taken
with a charge-coupled device camera.
Quantiﬁcation of -ENaC by real-time PCR. ROMK wild-type
and knockout mice were killed by injection of ketamine/xylazine
(ip) and subsequent cervical dislocation, and the kidneys were
collected and rapidly frozen until further use. Total mRNA was
extracted from 30 mg of tissue using an RNA Aqueous 4PCR kit
(Ambion) according to the manufacturer’s instruction. For RNA
extraction, kidneys was thawed in RNALater solution (Ambion),
transferred to lysis buffer, and homogenized on ice with an Elvehjem
potter. RNA was bound on columns and treated with DNAse for 15
min at 30°C to reduce genomic DNA contamination. Quantity and
purity of total eluted RNA were assessed by spectrometry and on
agarose gels. Each RNA sample was diluted to 200 ng/l, and 3 l
was used as a template for reverse transcription using a Taqman
Reverse Transcription kit (Applied Biosystems) in the presence of 2.5
M Random Hexamers primers (Applied Biosystems).
For reverse transcription, a 200-ng RNA template was diluted in a
20-l reaction mix that contained (ﬁnal concentrations) RT buffer
(1
), MgCl2 (5.5 mM), random hexamers (2.5 M), RNAse inhibitor
(0.4 U/l), the multiscribe RT enzyme (1.25 U/l), deoxyNTP mix
(500 M each), and RNAse-free water. Real-time PCR was per-
formed as described previously, according to the recommendations
supplied by Applied Biosystems (http://home.appliedbiosystems.
com). Primers for all genes of interest were designed using Primer
Express 2.0 software from Applied Biosystems. Primers were chosen
to result in amplicons of 70–100 bp that span intron-exon boundaries.
The speciﬁcity of all primers was ﬁrst tested on mRNA derived from
kidneys and resulted in a single product of the expected size (data not
shown). Probes were labeled with the reporter dye FAM at the 5-end
and the quencher dye TAMRA at the 3-end (Microsynth, Balgach,
Switzerland). The passive reference dye (ROX) was included in the
Taqman buffer supplied by the manufacturer. Twenty microliters of
cDNA obtained from the RT reaction was diluted to 100 l with
RNAse-free water. A 25-l PCR reaction volume was prepared using
5 l diluted cDNA as a template with sense and antisense primers (25
M each) and the labeled probe (5 M). The sequences for primers
used were the following: -actin forward primer: 5-CCACCGATC-
CACACAGAGTACTT-3, -actin reverse primer: 5-GACAGGAT-
GCAGAAGGAGATTACTG-3; and -ENaC forward primer: 5-GGT-
GCACGGTCAGGATGAG-3, -ENaC reverse primer: 5-TAGTTGC-
CTCCGAGGCTGTC-3. The Taqman Universal PCR Master Mix
(Applied Biosystems) was added to the ﬁnal volume. Reactions were
run in 96-well optical reaction plates using a Prism 7700 cycler
(Applied Biosystems).
Thermal cycles were set at 95°C (10 min) and the 40 cycles at 95
(15 s) and 60°C (1 min) with auto-ramp time. To analyze the data, the
threshold was set to 0.06 (value in the linear range of ampliﬁcation
curves). All the reactions were run in triplicate. The abundance of
-ENaC mRNA was calculated relative to a reference mRNA (mouse
-actin). Assuming an efﬁciency value of 2 (fold-increase in input
mRNA required to decrease the cycle number by 1), relative expres-
sion ratios were calculated as
R  2(Ct(-actin) Ct(-ENaC))
where Ct is the cycle number at the threshold.
In situ microperfusion of mouse kidney proximal tubules. The net
ﬂuid and HCO3 absorption in proximal tubules of age-matched adult
ROMK null and wild-type mice was assessed by in situ microperfu-
sion as described previously (32). Brieﬂy, superﬁcial proximal con-
voluted tubules were perfused at a rate of 15 nl/min with a solution
containing 115 mM NaCl, 25 mM NaHCO3, 4 mM KCl, 2 mM CaCl2,
1 mM MgSO4, 2 mM NaPO4, and 20 Ci/ml low-Na methoxy-
[3H]inulin (pH 7.4). The rates of net ﬂuid (Jv) and HCO3 (JHCO3)
absorption were calculated based on changes in the concentrations of
[3H]inulin and total CO2 as described previously (33). Jv and JHCO3
are expressed per minute per millimeter of proximal tubule.
RESULTS
Hormone levels. HPS is associated with increased urinary
excretion of PGE2 (12). Measurement of urinary PGE2 excre-
tion in ROMK null mice demonstrated a nonsigniﬁcant 1.5-
fold increase in PGE2 levels in (PGE2 wild-type: 1,099.9 
107.3 pg/day; Romk/: 15,743.0  209.2 pg/ day, n  12,
P  0.056). Plasma aldosterone was slightly but signiﬁcantly
higher in Romk/ animals than in Romk/ mice (260.3 
31.0 vs. 181.5  11.5 pg/ml, P 	 0.05). In agreement with
previous reports (12, 26) on enhanced plasma renin activity in
patients with Bartter’s syndrome, we found by Western blot-
ting and immunohistochemistry increased renin abundance in
kidneys from Romk/ mice (data not shown).
Changes in proximal tubule salt and water transport pro-
teins and transport rates in Romk/ mice. Figure 1 shows the
absence of ROMK expression in kidneys of Romk/ mice by
Western blotting of total crude membranes (Fig. 1A) and
Fig. 1. Absence of ROMK from kidneys from ROMK-deﬁcient mice (Romk/).
A: semiquantitative immunoblotting with homogenates from total kidneys of
wild-type (Romk/) and Romk/ mice. Fifty micrograms of crude mem-
brane preparations from each mouse were subjected to SDS-PAGE and
transferred to polyvinylidene diﬂuoride (PVDF) membrane and probed with
afﬁnity-puriﬁed anti-ROMK antibodies (Alamone Laboratories) and reprobed
for -actin after being stripped to control for loading. B: medullary rays in
renal cortex of Romk/ and Romk/ mice. Immunostaining for ROMK with
afﬁnity-puriﬁed rabbit-anti-ROMK antibody shows prominent ROMK staining
in the luminal membrane of some thick ascending limb (T) cells and in the
cytoplasm of some collecting duct (CD) cells that is absent from kidneys of
ROMK-deﬁcient mice. Scale bar  50 m.
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immunoﬂuorescence staining of tissue sections (Fig. 1B). The
abundance of the proximal tubule Na-transport proteins
Na/H exchanger isoform 3 (NHE3) and Na-phosphate
cotransporter type IIa (NaPi-IIa) was reduced by 10  6 and
37  12%, respectively (Fig. 2) in kidneys of Romk/ mice
compared with those of wild-type mice. This reduction may
reﬂect the relative decrease in proximal tubular mass due to the
increased fractional cortical tubular volume of distal convo-
luted tubules as described below. However, this 10% reduction
of NHE3 expression in kidneys of Romk/ mice did not
signiﬁcantly inﬂuence net Na and HCO3 absorption in prox-
imal tubules. As show in Fig. 3, Jv and JHCO3 absorption were
not signiﬁcantly different between Romk/ and Romk/
mice. Although the glomerular ﬁltration rate in Romk/ mice
was 50% of control Romk/ mice (4), the single-nephron
glomerular ﬁltration rate was not reduced in Romk/ mice
(21). Since NHE3 activity is ﬂow dependent (6), the 10%
reduction of NHE3 expression was not detectable by changes
in Jv and JHCO3 absorption at the ﬂow rate close to the normal
single-nephron glomerular ﬁltration rate in the proximal tu-
bule.
Changes in loop and distal tubule salt and water transport
proteins in Romk/ mice. NaCl absorption in the loop of
Henle is markedly reduced but not absent in Romk/ mice
(21), and these ROMK null mice exhibit a small remaining
responsiveness to loop diuretics (4). Thus we assessed the
abundance of the TAL-speciﬁc apical NKCC2 isoform in
Romk/ mice. In the absence of ROMK expression, NKCC2
was decreased in Romk/ mice by 42  16% (Fig. 4A). With
the use of the same antibody, immunoﬂuorescence revealed
NKCC2 in TAL segments of ROMK-deﬁcient mice (Fig. 4B).
The staining, however, was less prominent than in TAL seg-
ments of wild-type mice. The epithelial structure of the TAL
segments of both genotypes was similar.
In a companion study (4), we showed that the natriuretic
response to hydrochlorothiazide was exaggerated in Romk/
mice. Thus we assessed the expression of the DCT-speciﬁc
NCC and morphology of the DCT in Romk/ compared with
Romk/ mice. NCC abundance was markedly enhanced in
Romk/ mice by 130  36% (Fig. 5A). Overviews of renal
cortex in wild-type and Romk/ mice showed an increased
abundance of nephron segments positive for NCC (Fig. 5, B
and C). Higher magniﬁcations revealed a pronounced epithelial
hypertrophy of NCC-positive DCT proﬁles in ROMK-deﬁcient
mice (Fig. 5, D and E). Fractional DCT tubular volume in the
cortex was more than threefold greater in Romk/ compared
with Romk/mice (Fig. 5F). Interestingly, coimmunostain-
ings for NCC and ENaC for unequivocal identiﬁcation of
mouse DCT subsegments (16) showed that DCT hypertrophy
occurred predominately in the early rather then in the late DCT
segments. (Fig. 6, E and F). In the companion study (4), we
found that benzamil, an inhibitor of ENaC, did not increase
natriuresis in Romk/ mice, suggesting that ENaC activation
does not signiﬁcantly contribute to the compensation of the
Na transport defect in the TAL. Consistent with this assump-
tion, we found that plasma aldosterone levels were only
slightly elevated and that the renal mRNA expression of the
aldosterone-dependent -ENaC subunit was not changed in
Romk/ mice (Fig. 6B). Although immunoblotting of whole
kidney homogenates (Fig. 6A) revealed an increased abun-
dance for -ENaC by 345 85% (not signiﬁcant), -ENaC by
203 73% (not signiﬁcant), and -ENaC by 197 13% (P	
0.05), detailed immunohistochemical analysis of ﬁxed kidney
samples showed that the enhanced expression of ENaC sub-
units did not increase the cell surface abundance of ENaC. In
mice of both genotypes, -ENaC and -ENaC subunits were
seen diffusely distributed in the cytoplasm of the segment-
speciﬁc cells of the CNT and CCD (Fig. 6, D, F–H). Only
Fig. 2. Altered abundance of proximal tubular transport proteins in ROMK-
deﬁcient mice. Semiquantitative immunoblotting was performed with 50 g of
crude membrane preparations from Romk/ and Romk/ mouse kidneys.
Compared with wild-type mice, ROMK-deﬁcient mice exhibit reduced renal
abundance of Na-Pi cotransporter type IIa (NaPi-IIa) and Na/H exchanger
isoform 3 (NHE3).
Fig. 3. Fluid and bicarbonate absorption in kidney proximal tubules The net
ﬂuid (Jv) and bicarbonate (JHCO3) absorption were measured by microperfu-
sion of proximal tubules in situ in both Romk/ and Romk/ mice.
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the late DCT and the initial portion of the CNT of Romk/
mice revealed some staining for -ENaC (Fig. 6F) and
-ENaC (not shown) at the apical plasma membrane, similar
to wild-type mice in this study (Fig. 6D) and similar to
previous ﬁndings in normal mice and rats (16, 18, 19).
-ENaC was barely detectable by immunoﬂuorescence in all
segments of the CNT and collecting system in kidneys from
wild-type and ROMK-deﬁcient animals (data not shown).
Although there was variable expression of the AQP2 water
channel in both Romk/ and Romk/mice, the abundance of
AQP2 was unchanged in Romk/ mice (Fig.. 7A). AQP2
water channel staining appeared to be more luminal and pro-
nounced in the CNT and CCD of some but not all ROMK-
deﬁcient mice compared with wild-type animals, suggesting
broad interindividual variability (Fig. 7, B–D).
DISCUSSION
The antenatal Bartter’s syndromes present clinically as TAL
tubulopathies with a variable degree of salt and water loss
depending on the underlying gene defect (3, 10, 12, 29–31,
34). Previous work using loop diuretic-treated rats and mice
demonstrated an adaptive remodeling of the distal nephron
with compensatory growth and upregulation of NaCl-absorb-
ing proteins (9, 14). Similarly, inhibition of salt absorption in
the distal nephron as with thiazide treatment or after genetic
ablation of the NCC results in the compensatory hypertrophy
of the CNT and CCD segments (20). ROMK channel-deﬁcient
mice provide a genetic model with which to study the possible
Fig. 4. Reduced abundance and immunostaining for the thick ascending limb
of Henle’s loop (TAL)-speciﬁc Na-K-2Cl cotransporter (NKCC2/BSC1).
A: semiquantitative immunoblotting with 50 g of crude membrane prepara-
tions from Romk/ and Romk/ mouse kidneys. ROMK-deﬁcient mice
showed reduced abundance of the TAL-speciﬁc NKCC2. B: outer and inner
stripe (OS and IS, respectively) of renal outer medulla of Romk/ and
Romk/ mice. Immunostaining for NKCC2 is seen in the luminal membrane
of TAL in wild-type and ROMK-deﬁcient mice. The epithelial cells of TALs
in ROMK-deﬁcient mice do not show any gross abnormalities but apparently
reveal weaker NKCC2 immunoﬂuorescence than the TALs of wild-type mice.
Scale bar  50 m.
Fig. 5. Compensatory increased abundance in the thiazide-sensitive Na-Cl
cotransporter (NCC) and massive hypertrophy of the distal tubule in kidneys from
ROMK-deﬁcient mice. A: semiquantitative immunoblotting with 50 g of crude
membrane preparations from Romk/ and Romk/ mouse kidneys. ROMK-
deﬁcient mice showed increased abundance of distal convoluted tubule (DCT)-
speciﬁc NCC. B and C: overviews of renal cortex of Romk/ and Romk/mice.
Immunoﬂuorescence with rabbit anti-NCC antibodies reveals much higher density
of NCC-positive DCT proﬁles in the renal cortex of the Romk/ mouse than in
the renal cortex of the Romk/ mouse. Scale bar  200 m. D and E: higher
magniﬁcation of NCC-immunostained DCT proﬁles demonstrates the tremendous
hypertrophy of the DCT epithelium in ROMK-deﬁcient mice. Pictures were taken
at the same magniﬁcation. Scale bar20 m. F: fractional cortical volumes of
DCT and the cortical collecting system [connecting tubule (CNT) and cortical
collecting duct (CCD)] in Romk/ and Romk/mice. DCT and CNT/CCDwere
identiﬁed on account of their characteristic antibody-binding [DCT: NCC positive;
CNT/CCD: NCC negative; and -epithelial sodium channel (ENaC) positive] as
described in MATERIALS AND METHODS. The fractional cortical tubular volumes were
determined by the point-counting method, according to Weibel (35). Values are
means  SE from 4 individual mice in each group. *P 	 0.05 vs. Romk/ values.
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compensatory mechanisms involved in this type II Bartter’s
disease. We show that loss of ROMK is associated with
reduced expression of proximal tubular and TAL Na trans-
porters, DCT cell hypertrophy with increased DCT NCC abun-
dance, and slightly enhanced abundance of ENaC Na chan-
nels in the collecting system, which are, however, predomi-
nantly localized to intracellular compartments.
These results are in agreement with functional data obtained
in the same animals, as described in the companion study (4).
The reduction of NKCC2 expression and a reduced effect of
furosemide on the fractional Na excretion rate together dem-
onstrate that ROMK is critical for TAL function. The absence
of apparent structural changes in the TAL is consistent with
previous morphological studies using kidneys of furosemide-
treated rats (12, 13). Moreover, it appears that most of the lost
TAL function is compensated for by the subsequent distal
tubule as indicated by the massive hypertrophy of the DCT
epithelium, the increase in the expression levels of the thiazide-
Fig. 6. Abundance and localization of ENaC subunits. A: semiquantitative immunoblotting with 50 g of total membrane preparations from kidneys of Romk/
and Romk/ mice. The abundance of the -ENaC and -ENaC subunits is profoundly increased, whereas the expression of -ENaC appears to be unaffected.
Polyvinylidene diﬂuoride (PVDF) membranes were stripped and reprobed for -actin to ensure equal loading. B: relative abundance of mRNA for the
aldosterone-regulated -ENaC as determined by real-time PCR and normalized against -actin mRNA. C–F: consecutive cryosections of renal cortex of
Romk/ (C and D) and Romk/ (E and F) mice immunostained for NCC (C and E) and -ENaC (D and F). Note the marked hypertrophy of early DCT (D)
proﬁles, (characterized by strong NCC, but no -ENaC immunoreactivity) in Romk/ mice compared with early DCTs of Romk/ mice. The epithelial heights
of late DCT proﬁles (asterisks), which are characterized by costaining for NCC and -ENaC, and of CNT proﬁles (CN) do not apparently vary between the two
mice. Similarly, mice of both genotypes show apical -ENaC immunostaining only in the late DCT (asterisk) and in the directly adjacent early connecting tubule
(CN). In farther downstream localized CNT (CN*) segments, -ENaC is almost exclusively localized to intracellular compartments in mice of both genotypes.
Scale bar  40 m. G and H: higher magniﬁcation of CNT proﬁles from Romk/ and Romk/ mice demonstrate the predominant intracellular localization
of -ENaC in the CNTs from mice of both genotypes. Unstained cells in the CNT epithelia represent intercalated cells, which are known to be ENaC negative.
Scale bar  40 m.
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sensitive NaCl-cotransporter NCC, and the exaggerated re-
sponse in urinary Na excretion after application of thiazide
diuretics. The fractional cortical tubular volume of the DCT
increased 300%, which readily explains the previously re-
ported higher volume density of distal tubules in Romk/
mice (21). The structural changes in the DCT are reminiscent
of those seen in furosemide-treated rats. In these rats, the
pharmacological inhibition of TAL function also induced DCT
cell growth (13, 14), which was, however, less dramatic as that
seen in Romk/ mice. Although not speciﬁcally addressed
in the present study, results from furosemide-treated rats
indicate that the observed adaptive DCT growth originates
from both epithelial hypertrophy (9, 14) and epithelial
hyperplasia (17). PGE2 has been implicated in the hypertro-
phy of distal nephron segments but has also been made
responsible, at least in part, for the pathophysiology ob-
served in Bartter’s syndrome (12). Hence, it remains to be
clariﬁed whether PGE2 is part of the compensatory response
or rather contributes to the observed renal defect. ROMK-
deﬁcient mice will provide an excellent model for the study
of this problem in the future.
Although Romk/ mice have a severe Na-transporting
defect in the TAL, the animals are apparently more or less in
sodium balance, as indicated by the only slightly elevated
plasma renin and aldosterone levels. Consistent with the rather
minor effect on plasma aldosterone levels, Romk/ mice did
not show any signiﬁcant upregulation of the aldosterone-
dependent -ENaC subunit at the mRNA level and no effect on
the cell surface localization of all three ENaC subunits. Simi-
larly, the renal clearance experiments (see Ref. 4, the compan-
ion study) did not show any signiﬁcant difference between the
amiloride-sensitive portion of renal Na reabsorption in wild-
type and ROMK-deﬁcient mice. Together with the lack of any
effect on the fractional cortical tubular volume of the collecting
system, these data strongly suggest that ENaC-mediated Na
transport in the collecting system is not signiﬁcantly activated
and therefore does not signiﬁcantly contribute to the compen-
sation of the renal Na transport defect in ROMK-deﬁcient
mice. This stands in sharp contrast to the compensatory mech-
anisms in NCC-deﬁcient mice. These mice revealed elevated
plasma aldosterone levels, increased ENaC cell surface
abundance, and a marked epithelial hypertrophy of the renal
connecting tubule but not of the collecting duct (20). Taken
together, these ﬁndings suggest that the genetic salt trans-
port defect in a given distal tubular segment is largely
compensated by structural and functional adaptations in the
directly following downstream tubular segment. Consistent
with this hypothesis is our observation in the present study
that the DCT hypertrophy in Romk/ mice is most pro-
nounced in the early DCT.
Interestingly, no clear effect was found in AQP2 water
channels. Despite the fact that Romk/ animals are polyuric
and that some of them showed a more pronounced apical
AQP2 staining with the appearance of AQP2 channels also in
the CNT, this effect was not observed in all animals. Immu-
noblotting also showed no signiﬁcant difference between wild-
type and knockout animals.
In summary, ablation of ROMK channels in the TAL in the
mouse kidney leads to loss of TAL function. Excessive water
and salt loss are prevented by a combination of hypertrophy of
the subsequent distal nephron and upregulation of NaCl reab-
sorption via the thiazide-sensitive NCC cotransporter and to a
lesser extent via ENaC. Upregulation of AQP2 channels ap-
pears to play a minor role and was not observed in all animals.
Thus the ROMK-deﬁcient mouse model provides good evi-
dence for compensatory mechanisms in Bartter’s syndrome
and TAL dysfunction and will allow study of the mechanism
underlying these compensatory processes.
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Fig. 7. Expression and localization of the vasopressin-regulated aqua-
porin-2 (AQP2) water channel. A: semiquantitative immunoblotting for
AQP2 with total membrane preparations from total kidney of Romk/ and
Romk/ animals reveals no signiﬁcant difference between both genotypes.
B–D: medullary rays in renal cortex of Romk/ and Romk/ mice.
Immunostaining for AQP2 with afﬁnity-puriﬁed rabbit anti-AQP2 anti-
body. B: AQP2 immunoﬂuorescence is visible in the luminal membrane
and in the cytoplasm of collecting duct principal cells. Intercalated cells are
AQP2 negative. The collecting ducts of ROMK-deﬁcient mice often exhibit
more pronounced intracellular and apical AQP2 immunostaining (C).
In some collecting duct proﬁles of ROMK-deﬁcient mice (D), AQP2 is
almost exclusively localized at the apical plasma membrane. Scale bar 
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